Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT

MLA

Rovó, A., et al. “Outcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS-a Study of the CMWP of the EBMT.” Rovó , A , Gras , L , Piepenbroek , B , Kroeger , N , Reinhardt , HC , Radujkovic , A , Blaise , D , Kobbe , G , Niityvuopio , R , Platzbecker , U , Sockel , K , Hunault-Berger , M , Cornelissen , JJ , Forcade , E , Bourhis , JH , Chalandon , Y , Kinsella , F , Nguyen-Quoc , S , Maertens , J , Elmaagacli , A , Mordini , N , Hayden , P , Raj , K , Drozd-Sokolowska , J , de Wreede , LC , Mclornan , DP , Robin , M , Yakoub-Agha , I & Onida , F 2024 , ’ Outcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS-a Study of the CMWP of the EBMT ’ , American Journal of Hematology , Vol. 99 , No. 2 , Pp. 203-215 , 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1415729903&authtype=sso&custid=ns315887.

APA

Rovó, A., Gras, L., Piepenbroek, B., Kroeger, N., Reinhardt, H., Radujkovic, A., Blaise, D., Kobbe, G., Niityvuopio, R., Platzbecker, U., Sockel, K., Hunault-Berger, M., Cornelissen, J., Forcade, E., Bourhis, J., Chalandon, Y., Kinsella, F., Nguyen-Quoc, S., Maertens, J., … Onida, F. (2024). Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT. Rovó , A , Gras , L , Piepenbroek , B , Kroeger , N , Reinhardt , HC , Radujkovic , A , Blaise , D , Kobbe , G , Niityvuopio , R , Platzbecker , U , Sockel , K , Hunault-Berger , M , Cornelissen , JJ , Forcade , E , Bourhis , JH , Chalandon , Y , Kinsella , F , Nguyen-Quoc , S , Maertens , J , Elmaagacli , A , Mordini , N , Hayden , P , Raj , K , Drozd-Sokolowska , J , de Wreede , LC , Mclornan , DP , Robin , M , Yakoub-Agha , I & Onida , F 2024 , ’ Outcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS-a Study of the CMWP of the EBMT ’ , American Journal of Hematology , Vol. 99 , No. 2 , Pp. 203-215 .

Chicago

Rovó, A, L Gras, B Piepenbroek, N Kroeger, Hc Reinhardt, A Radujkovic, D Blaise, et al. 2024. “Outcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS-a Study of the CMWP of the EBMT.” Rovó , A , Gras , L , Piepenbroek , B , Kroeger , N , Reinhardt , HC , Radujkovic , A , Blaise , D , Kobbe , G , Niityvuopio , R , Platzbecker , U , Sockel , K , Hunault-Berger , M , Cornelissen , JJ , Forcade , E , Bourhis , JH , Chalandon , Y , Kinsella , F , Nguyen-Quoc , S , Maertens , J , Elmaagacli , A , Mordini , N , Hayden , P , Raj , K , Drozd-Sokolowska , J , de Wreede , LC , Mclornan , DP , Robin , M , Yakoub-Agha , I & Onida , F 2024 , ’ Outcomes of CMML Patients Undergoing Allo-HCT Are Significantly Worse Compared to MDS-a Study of the CMWP of the EBMT ’ , American Journal of Hematology , Vol. 99 , No. 2 , Pp. 203-215 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1415729903&authtype=sso&custid=ns315887.